eLife (Oct 2020)
GATA6 mutations in hiPSCs inform mechanisms for maldevelopment of the heart, pancreas, and diaphragm
- Arun Sharma,
- Lauren K Wasson,
- Jon AL Willcox,
- Sarah U Morton,
- Joshua M Gorham,
- Daniel M DeLaughter,
- Meraj Neyazi,
- Manuel Schmid,
- Radhika Agarwal,
- Min Young Jang,
- Christopher N Toepfer,
- Tarsha Ward,
- Yuri Kim,
- Alexandre C Pereira,
- Steven R DePalma,
- Angela Tai,
- Seongwon Kim,
- David Conner,
- Daniel Bernstein,
- Bruce D Gelb,
- Wendy K Chung,
- Elizabeth Goldmuntz,
- George Porter,
- Martin Tristani-Firouzi,
- Deepak Srivastava,
- Jonathan G Seidman,
- Christine E Seidman,
- Pediatric Cardiac Genomics Consortium
Affiliations
- Arun Sharma
- ORCiD
- Department of Genetics, Harvard Medical School, Boston, United States; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, United States; Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, United States
- Lauren K Wasson
- ORCiD
- Department of Genetics, Harvard Medical School, Boston, United States; Howard Hughes Medical Institute, Harvard Medical School, Boston, United States
- Jon AL Willcox
- Department of Genetics, Harvard Medical School, Boston, United States
- Sarah U Morton
- Department of Genetics, Harvard Medical School, Boston, United States; Division of Newborn Medicine, Boston Children's Hospital, Boston, United States
- Joshua M Gorham
- Department of Genetics, Harvard Medical School, Boston, United States
- Daniel M DeLaughter
- Department of Genetics, Harvard Medical School, Boston, United States
- Meraj Neyazi
- Department of Genetics, Harvard Medical School, Boston, United States; Hannover Medical School, Hannover, Germany
- Manuel Schmid
- Department of Genetics, Harvard Medical School, Boston, United States; Deutsches Herzzentrum München, Technische Universität München, Munich, Germany
- Radhika Agarwal
- Department of Genetics, Harvard Medical School, Boston, United States
- Min Young Jang
- Department of Genetics, Harvard Medical School, Boston, United States
- Christopher N Toepfer
- Department of Genetics, Harvard Medical School, Boston, United States; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom; Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
- Tarsha Ward
- Department of Genetics, Harvard Medical School, Boston, United States
- Yuri Kim
- Department of Genetics, Harvard Medical School, Boston, United States
- Alexandre C Pereira
- Department of Genetics, Harvard Medical School, Boston, United States; Laboratory of Genetics and Molecular Cardiology, Heart Institute, Medical School of University of Sao Paulo, Sao Paulo, Brazil
- Steven R DePalma
- Department of Genetics, Harvard Medical School, Boston, United States
- Angela Tai
- Department of Genetics, Harvard Medical School, Boston, United States
- Seongwon Kim
- Department of Genetics, Harvard Medical School, Boston, United States
- David Conner
- Department of Genetics, Harvard Medical School, Boston, United States
- Daniel Bernstein
- Department of Pediatrics, Stanford University School of Medicine, Stanford, United States
- Bruce D Gelb
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, United States
- Wendy K Chung
- Department of Medicine, Columbia University Medical Center, New York, United States
- Elizabeth Goldmuntz
- ORCiD
- Department of Pediatrics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States
- George Porter
- Department of Pediatrics, University of Rochester Medical Center, Rochester, United States
- Martin Tristani-Firouzi
- Division of Pediatric Cardiology, University of Utah School of Medicine, Salt Lake City, United States
- Deepak Srivastava
- ORCiD
- Gladstone Institutes, San Francisco, United States
- Jonathan G Seidman
- ORCiD
- Department of Genetics, Harvard Medical School, Boston, United States
- Christine E Seidman
- ORCiD
- Department of Genetics, Harvard Medical School, Boston, United States; Howard Hughes Medical Institute, Harvard Medical School, Boston, United States; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, United States
- Pediatric Cardiac Genomics Consortium
- DOI
- https://doi.org/10.7554/eLife.53278
- Journal volume & issue
-
Vol. 9
Abstract
Damaging GATA6 variants cause cardiac outflow tract defects, sometimes with pancreatic and diaphragmic malformations. To define molecular mechanisms for these diverse developmental defects, we studied transcriptional and epigenetic responses to GATA6 loss of function (LoF) and missense variants during cardiomyocyte differentiation of isogenic human induced pluripotent stem cells. We show that GATA6 is a pioneer factor in cardiac development, regulating SMYD1 that activates HAND2, and KDR that with HAND2 orchestrates outflow tract formation. LoF variants perturbed cardiac genes and also endoderm lineage genes that direct PDX1 expression and pancreatic development. Remarkably, an exon 4 GATA6 missense variant, highly associated with extra-cardiac malformations, caused ectopic pioneer activities, profoundly diminishing GATA4, FOXA1/2, and PDX1 expression and increasing normal retinoic acid signaling that promotes diaphragm development. These aberrant epigenetic and transcriptional signatures illuminate the molecular mechanisms for cardiovascular malformations, pancreas and diaphragm dysgenesis that arise in patients with distinct GATA6 variants.
Keywords